OPTIMAL USE OF LIPID-LOWERING THERAPY AFTER ACUTE CORONARY SYNDROMES: A Position Paper endorsed by the International Lipid Expert Panel (ILEP)
M Banach, PE Penson, ACS EuroPath Central & South European Countries Project et al.
KEYWORDS
PCSK9 inhibitors; combination therapy; effectiveness; ezetimibe; safety; statins
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.